|
EIF2C4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.928810E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.529600E-01 |
| Normal-vs-Stage2 |
5.576400E-02 |
| Normal-vs-Stage3 |
2.355200E-01 |
| Normal-vs-Stage4 |
1.019830E-01 |
| Stage1-vs-Stage2 |
1.501590E-01 |
| Stage1-vs-Stage3 |
4.917400E-01 |
| Stage1-vs-Stage4 |
2.631400E-01 |
| Stage2-vs-Stage3 |
3.975200E-01 |
| Stage2-vs-Stage4 |
7.507400E-01 |
| Stage3-vs-Stage4 |
5.903800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.388400E-01 |
| Normal-vs-AfricanAmerican |
9.927000E-01 |
| Normal-vs-Asian |
2.383200E-01 |
| Caucasian-vs-AfricanAmerican |
5.643200E-01 |
| Caucasian-vs-Asian |
6.010000E-01 |
| AfricanAmerican-vs-Asian |
3.538000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.845630E-01 |
| Normal-vs-Female |
3.123600E-01 |
| Male-vs-Female |
6.571800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.781000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.481840E-01 |
| Normal-vs-Age(61-80Yrs) |
5.107600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.199040E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.638000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.477700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.438200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.559800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.771800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.804400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.825000E-01 |
| Classical-VS-Follicular |
9.098800E-03 |
| Classical-VS-Other |
1.990160E-01 |
| Classical-VS-Normal |
7.514600E-01 |
| Tall-VS-Follicular |
3.667800E-01 |
| Tall-VS-Other |
3.281800E-01 |
| Tall-VS-Normal |
3.569000E-01 |
| Follicular-VS-Other |
7.050400E-01 |
| Follicular-VS-Normal |
3.380400E-02 |
| Other-VS-Normal |
1.123220E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.296200E-02 |
| Normal-vs-N1 |
3.093400E-01 |
| N0-vs-N1 |
6.378200E-01 |
|
|
